DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Glecaprevir; pibrentasviris the generic ingredient in one branded drug marketed by Abbvie Inc and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Glecaprevir; pibrentasvir has four hundred and forty-one patent family members in forty-four countries.
One supplier is listed for this compound.
Recent Clinical Trials for glecaprevir; pibrentasvir
Identify potential brand extensions & 505(b)(2) entrants
|NYU Langone Health||Early Phase 1|
|Massachusetts General Hospital||Phase 4|
|Mayo Clinic||Phase 4|
Pharmacology for glecaprevir; pibrentasvir
|Country||Patent Number||Estimated Expiration|
|South Korea||101990279||Get Started for $10|
|China||103819459||Get Started for $10|
|Israel||223535||Get Started for $10|
|Mexico||2012014384||Get Started for $10|
|Spain||2624980||Get Started for $10|
|Taiwan||201216979||Get Started for $10|
|Japan||2020059696||Get Started for $10|
|>Country||>Patent Number||>Estimated Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2618831||C02618831/01||Switzerland||Get Started for $10||PRODUCT NAME: GLECAPREVIR; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66472 22.09.2017|
|2368890||122015000039||Germany||Get Started for $10||PRODUCT NAME: OMBITASVIR; REGISTRATION NO/DATE: EU/1/14/982 20150115|
|2692346||LUC00038||Luxembourg||Get Started for $10||PRODUCT NAME: PIBRENTASVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1213 20170728|
|2692346||1790050-7||Sweden||Get Started for $10||PRODUCT NAME: PIBRENTASVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/17/1213 20170728|
|2618831||300 50016-2017||Slovakia||Get Started for $10||PRODUCT NAME: GLECAPREVIR VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/17/1213 20170728|
|2692346||51/2017||Austria||Get Started for $10||PRODUCT NAME: PIBRENTASVIR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/17/1213 (MITTEILUNG) 20170728|
|2692346||PA2017033,C2692346||Lithuania||Get Started for $10||PRODUCT NAME: PIBRENTASVIRAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/17/1213 20170726|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.